Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models
Samuel Y. Ng(National Cancer Institute), Raphael Koch(Harvard University), Julie K. Jang(University of Southern California), Giorgio Inghirami(Cornell University), Joshua M. Dempster(Broad Institute), Danilo Fiore(Institute for Experimental Endocrinology and Oncology), Manuel Aivado(Aileron (United States)), Brian J. Haas(Broad Institute), Elizabeth A. Morgan(Brigham and Women's Hospital), Ahmet Doǧan(Memorial Sloan Kettering Cancer Center), David M. Weinstock(Broad Institute), Kay Shigemori(Dana-Farber Cancer Institute), David M. Dorfman(Brigham and Women's Hospital), Jon C. Aster(Brigham and Women's Hospital), Abner Louissaint(Massachusetts General Hospital), Andrew D. Cherniack(Broad Institute), Amitkumar Mehta(University of Alabama at Birmingham), Solimar Santiago(Aileron (United States)), Amanda L. Christie(Dana-Farber Cancer Institute), Neekesh V. Dharia(Broad Institute), Mark A. Murakami(Harvard University), Alexandria Van Scoyk(Dana-Farber Cancer Institute), Xintao Qiu(Dana-Farber Cancer Institute), Nicolas A. Cordero(Dana-Farber Cancer Institute), Jian-Guo Ren(Aileron (United States)), Francisca Vázquez(Broad Institute), Vincent Guerlavais(Aileron (United States)), Aaron R. Thorner(Center for Cancer Research), Mäneka Puligandla(Dana-Farber Cancer Institute), D. Allen Annis(Aileron (United States)), Galen F. Gao(Broad Institute), William C. Hahn(Broad Institute), Henry W. Long(Dana-Farber Cancer Institute), Steven M. Horwitz(Memorial Sloan Kettering Cancer Center), Aviad Tsherniak(Broad Institute), Christopher Lo(University of Toronto), Robin M. Meyers(Broad Institute), Alan L. Epstein(University of Southern California), Valentina Nardi(Biopredic (France)), Eric D. Jacobsen(Dana-Farber Cancer Institute), David E. Root(Broad Institute), Mansoor N. Saleh(Georgia Cancer Specialists), Kristen E. Stevenson(Dana-Farber Cancer Institute), Sara Morrow(Durham University), Mahmoud Ghandi(Broad Institute), Yanming Zhang(Memorial Sloan Kettering Cancer Center), Noriaki Yoshida(Dana-Farber Cancer Institute)
Cited by 114
Related Papers
Full-length transcriptome assembly from RNA-Seq data without a reference genome
|Nature Biotechnology|2011|22.7k
UCHIME improves sensitivity and speed of chimera detection
|Bioinformatics|2011|15.5k
De novo transcript sequence reconstruction from RNA-seq using the Trinity platform for reference generation and analysis
|Nature Protocols|2013|9.1k
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k